CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that John Climaco,...

TüV Rheinland Certifies the QNX ® Hypervisor 2.0 for Safety with ISO 26262 Functional Safety Integrity Level (ASIL D) WATERLOO, Canada and COLOGNE, Germany, Dec. 9, 2019 /PRNewswire/ --...

Clarivate Analytics Plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Jerre Stead, Executive Chairman...

The Construction Industry Council (CIC) held a press conference today, announcing the "Construction Innovation Expo 2019" (CIExpo) which is jointly organised by the CIC and Development Bureau, and...

Antios Therapeutics, Inc. ("Antios"), a biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases, today announced the acceptance of an oral...

Charter Communications, Inc. (NASDAQ: CHTR) today announced that Tom Rutledge, Chairman and Chief Executive Officer, will participate in the UBS Global TMT Conference in New York, NY today,...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") presented new findings from its pivotal Phase 3 SIERRA trial for Iomab-B (Iodine-131 apamistamab) at the 2019 American Society of...

NetDragon Websoft Holdings Limited ("NetDragon" or "the Company", Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that, the Company...

Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced new interim results from the Company's ongoing Phase 2a study of cerdulatinib, an investigational, oral SYK/JAK inhibitor, in...

iQIYI, Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service in China, held its annual signature iQIYI Scream Night in Beijing on December 6th....